Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Otolaryngology
•
Hospital Medicine
•
Primary Care
•
General Primary Care
•
General Hospital Medicine
Would you empirically cover anaerobic organisms when treating non-purulent facial cellulitis if oral source (e.g., mucocutaneous lesion) was suspected?
Related Questions
Have you started using novel oral antibiotics such as gepotidacin for MDR UTIs and STIs?
What is your approach to a situation where DILI is suspected secondary to an important medication (e.g., anticoagulation, antibiotics, etc.), but the diagnosis is uncertain and the liver injury is relatively mild?
What is your approach to iron supplementation in patients with an active infection?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
How do you decide when to initiate antibiotics for superimposed bacterial pneumonia in patients with influenza?
How do you evaluate for an ascending UTI in a patient with a urostomy?
How do you consider sending fungal studies in a patient with pneumonia?
What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
How do you consider and approach transition to hospice in a patient with HFrEF who does not appear to tolerate GDMT?
How do you decide when to use acid-suppressive medications for GI prophylaxis when patients are on prolonged corticosteroid therapy?
